p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.

Moreno-Galindo, Carla

p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas. [electronic resource] - Oral oncology Feb 2014 - 128-34 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-0593

10.1016/j.oraloncology.2013.10.018 doi


Adult
Aged
Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--metabolism
Carcinoma, Squamous Cell--drug therapy
Caspase 3--metabolism
Cisplatin--therapeutic use
Cyclin D1--metabolism
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinase Inhibitor p21--metabolism
ErbB Receptors--metabolism
Female
Fluorouracil--therapeutic use
Humans
Hypopharyngeal Neoplasms--drug therapy
Hypoxia-Inducible Factor 1, alpha Subunit--metabolism
Laryngeal Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Proteins--metabolism
Prognosis
Proliferating Cell Nuclear Antigen--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Proto-Oncogene Proteins c-bcl-2--metabolism
Tumor Suppressor Protein p53--metabolism